Camille Terfve - October 29, 2024 Alchemab: the art of AI antibody discovery Alchemab’s artificial intelligence platform enables the identification of antibodies for some of ...
Anna Mudge - October 29, 2024 GENE-ius options to protect gene therapies Gene therapies involve treating patients by manipulating their genetic makeup. Such therapies may ...
Matthew Naylor - October 28, 2024 UPC Weekly - UPC confirms approach to inventive step for life science inventions 2024 Week 43 10x Genomics and NanoString have been duking it out at the UPC since the court opened ...
Rebecca Tollervey - October 28, 2024 Claim Requests found Inadmissible in EPO Appeal Proceedings: What Can Proprietors Do? Since the EPO’s Rule of Procedure of the Boards of Appeal (RPBA) were revised in 2020, parties have ...
Eleanor Maciver - October 22, 2024 Ask a VC: how important is it for greentech startups to have an IP strategy? We asked Jonathan Tudor, Investment Partner at Clean Growth Fund, to explain how venture ...
Matthew Naylor - October 21, 2024 UPC Weekly - Light emitting diode patent falls into a black hole of invalidity 2024 Week 42 Last week we did a deep dive into some LED technology to explain the decision of the ...
Joanna Smith - October 17, 2024 Chambers & Partners 2025 legal guide - Band 1 We are proud to have once again been ranked Band 1 (gold) in Chambers & Partners 2025 legal ...
Chris Denison - October 14, 2024 No referral to the Enlarged Board of Appeal on the requirement for description amendments In a keenly-awaited decision (T 0056/21) issued today, Technical Board of Appeal 3.3.04 (Pregetter, ...
